Search research articles
Contact Us
Filters
Showing results (111-120 of 165) with videos related to
Page
of 17
Sort By:
ACS Infectious Diseases
|
April 2, 2025
Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target Vulnerability
Mingqian Wang, YongLe He, Siobhan A Cohen, et al.
Nature Communications
|
September 13, 2024
Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease
Nehaben A Gujarati, Bismark O Frimpong, Malaika Zaidi, et al.
Neurobiology of Disease
|
December 3, 2017
The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein
Michael P Nelson, Michel Boutin, Tonia E Tse, et al.
Molecular Cancer Therapeutics
|
September 5, 2024
TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer Cells
Michael Giarrizzo, Joseph F LaComb, Hetvi R Patel, et al.
Molecular Cancer Therapeutics
|
February 20, 2007
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition
Elizabeth Buck, Alexandra Eyzaguirre, Sharon Barr, et al.
British Journal of Neurosurgery
|
May 10, 2023
Volume reduction with surgery for ICH: when is it effective? Analysis of the CT scans from the STICH II trial
Barbara A Gregson, Stephen Metcalfe, Ahmed Iqbal, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
<i>Fosl2</i> regulates the transition from parietal epithelial cells to myofibroblasts in the kidney
Robert Bronstein, Monica P Revelo, Fatima Sheikh, et al.
Oncogene
|
October 3, 2019
Correction: PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation
Mohamed F Salama, Mengling Liu, Christopher J Clarke, et al.
Oncogene
|
August 18, 2019
PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation
Mohamed F Salama, Mengling Liu, Christopher J Clarke, et al.
Cancer Research
|
September 15, 1991
The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood
A Strife, C Lambek, A Perez, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 165) with videos related to
Sort By:
Page
of 17
ACS Infectious Diseases
|
April 2, 2025
Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target Vulnerability
Mingqian Wang, YongLe He, Siobhan A Cohen, et al.
Nature Communications
|
September 13, 2024
Podocyte-specific KLF6 primes proximal tubule CaMK1D signaling to attenuate diabetic kidney disease
Nehaben A Gujarati, Bismark O Frimpong, Malaika Zaidi, et al.
Neurobiology of Disease
|
December 3, 2017
The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein
Michael P Nelson, Michel Boutin, Tonia E Tse, et al.
Molecular Cancer Therapeutics
|
September 5, 2024
TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer Cells
Michael Giarrizzo, Joseph F LaComb, Hetvi R Patel, et al.
Molecular Cancer Therapeutics
|
February 20, 2007
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition
Elizabeth Buck, Alexandra Eyzaguirre, Sharon Barr, et al.
British Journal of Neurosurgery
|
May 10, 2023
Volume reduction with surgery for ICH: when is it effective? Analysis of the CT scans from the STICH II trial
Barbara A Gregson, Stephen Metcalfe, Ahmed Iqbal, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
<i>Fosl2</i> regulates the transition from parietal epithelial cells to myofibroblasts in the kidney
Robert Bronstein, Monica P Revelo, Fatima Sheikh, et al.
Oncogene
|
October 3, 2019
Correction: PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation
Mohamed F Salama, Mengling Liu, Christopher J Clarke, et al.
Oncogene
|
August 18, 2019
PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation
Mohamed F Salama, Mengling Liu, Christopher J Clarke, et al.
Cancer Research
|
September 15, 1991
The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood
A Strife, C Lambek, A Perez, et al.
Page
of 17